152 related articles for article (PubMed ID: 20885995)
1. A global health partnership's use of time-limited support to catalyze health practice change: the case of GAVI's Injection Safety Support.
Levin A; Fang A; Hansen PM; Pyle D; Dia O; Schwalbe N
PLoS One; 2010 Sep; 5(9):e12986. PubMed ID: 20885995
[TBL] [Abstract][Full Text] [Related]
2. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
[TBL] [Abstract][Full Text] [Related]
3. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
[TBL] [Abstract][Full Text] [Related]
4. Measles supplementary immunization activities and GAVI funds as catalysts for improving injection safety in Africa.
Hoekstra EJ; van den Ent MM; Dao H; Khalaf H; Salovaara A
J Infect Dis; 2011 Jul; 204 Suppl 1():S190-7. PubMed ID: 21666161
[TBL] [Abstract][Full Text] [Related]
5. Strategies for financial sustainability of immunization programs: a review of the strategies from 50 national immunization program financial sustainability plans.
Kamara L; Milstien JB; Patyna M; Lydon P; Levin A; Brenzel L
Vaccine; 2008 Dec; 26(51):6717-26. PubMed ID: 18955100
[TBL] [Abstract][Full Text] [Related]
6. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
7. Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).
Gandhi G
BMC Public Health; 2015 Nov; 15():1198. PubMed ID: 26621528
[TBL] [Abstract][Full Text] [Related]
8. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
[TBL] [Abstract][Full Text] [Related]
9. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
[TBL] [Abstract][Full Text] [Related]
10. Introducing auto-disable syringes to the national immunization programme in Madagascar.
Drain PK; Ralaivao JS; Rakotonandrasana A; Carnell MA
Bull World Health Organ; 2003; 81(8):553-60. PubMed ID: 14576886
[TBL] [Abstract][Full Text] [Related]
11. Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries.
Saxenian H; Hecht R; Kaddar M; Schmitt S; Ryckman T; Cornejo S
Health Policy Plan; 2015 Mar; 30(2):197-205. PubMed ID: 24510369
[TBL] [Abstract][Full Text] [Related]
12. The GAVI Financing Task Force: one model of partner collaboration.
Milstien JB; Kamara L; Lydon P; Mitchell V; Landry S
Vaccine; 2008 Dec; 26(51):6699-705. PubMed ID: 19306508
[TBL] [Abstract][Full Text] [Related]
13. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
Brenzel L
Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
[TBL] [Abstract][Full Text] [Related]
14. Perceptions of the usefulness of external support to immunization coverage in Chad: an analysis of the GAVI-Alliance cash-based support.
Ferrinho P; Dramé M; Tumusiime P
Pan Afr Med J; 2013; 15():44. PubMed ID: 24106572
[TBL] [Abstract][Full Text] [Related]
15. Reuse prevention syringes for reconstitution of lyophilized vaccines: Operational study and UNICEF plans for expanding introduction.
Fleming JA; Hoekstra EJ; Moniaga V; Widjaya A; Soepardi J; Supartha N; Salovaara A; Khamassi S; Nelson C
Int J Occup Environ Health; 2009; 15(1):9-13. PubMed ID: 19267121
[TBL] [Abstract][Full Text] [Related]
16. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
[TBL] [Abstract][Full Text] [Related]
17. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries.
Drain PK; Nelson CM; Lloyd JS
Bull World Health Organ; 2003; 81(10):726-31. PubMed ID: 14758432
[TBL] [Abstract][Full Text] [Related]
18. Perspective and investments in health system strengthening of Gavi, the Vaccine Alliance: a content analysis of health system strengthening-specific funding.
Tsai FJ; Lee H; Fan VY
Int Health; 2016 Jul; 8(4):246-52. PubMed ID: 26612851
[TBL] [Abstract][Full Text] [Related]
19. Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction.
Shen AK; Weiss JM; Andrus JK; Pecenka C; Atherly D; Taylor K; McQuestion M
Health Aff (Millwood); 2016 Feb; 35(2):272-6. PubMed ID: 26858380
[TBL] [Abstract][Full Text] [Related]
20. Strategic donor behaviour and country vulnerability in health aid transitions.
Mao W; McDade KK; Ogbuoji O; Yamey G; Bermeo SB
BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 37940202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
